Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 1.5 % |
3 Month Return | -35.54 % |
1 Year Return | + 104.89 % |
Market Stats | |
Previous Close | ₹242.90 |
Open | ₹244.50 |
Volume | 1.59L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹2,013.45Cr |
P/E Ratio | 34.6 |
PEG Ratio | 10.3 |
Market Cap | ₹2,013.45 Cr |
P/B Ratio | 2.78 |
EPS | 5.81 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 9.28 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹2,013.45 Cr | 100.85% | 0.67 | ₹49 Cr | ₹709 Cr | |
NA | ₹435.76 Cr | 272.24% | 0.54 | ₹28 Cr | ₹601 Cr | |
NA | ₹15.41 Cr | 278.33% | 0.50 | NA | NA | |
BUY | ₹23,100.09 Cr | 3.59% | 0.52 | NA | NA | |
NA | ₹706.49 Cr | -0.07% | 0.57 | ₹9 Cr | ₹179 Cr |
Organisation | SMS Pharmaceuticals Ltd |
Headquarters | Hyderabad |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for SMS Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
FII Holding Up
Foreign Institutions have increased holdings from 0.17% to 0.52% in Sep 2024 quarter
Best in 1 Year
In the last 1 year, SMSPHARMA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
MF Holding Up
Mutual Funds have increased holdings from 2.13% to 2.55% in Sep 2024 quarter
Revenue Rich
Revenue is up for the last 2 quarters, 165.82 Cr → 198.05 Cr (in ₹), with an average increase of 16.3% per quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 64.67% of holdings in Sep 2024 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 135.8% return, outperforming this stock by 33.0%
Price Dip
In the last 3 months, SMSPHARMA stock has moved down by -33.4%
Profit Down
Netprofit is down for the last 3 quarters, 17.28 Cr → 14.1 Cr (in ₹), with an average decrease of 9.5% per quarter
Retail Holding Down
Retail Investor have decreased holdings from 33.03% to 32.26% in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 64.67% | 0.00 | |
Foreign Institutions | 0.52% | 203.98 | |
Mutual Funds | 2.55% | 19.42 | |
Retail Investors | 32.26% | ||
Others | 0% | 0.00 |
SMS Pharmaceuticals Ltd in the last 5 years
Lowest (-163.97x)
June 20, 2023
Today (34.60x)
December 19, 2024
Industry (56.23x)
December 19, 2024
Highest (2093.00x)
November 11, 2022
SMS Pharmaceuticals Ltd’s net profit jumped 20.2% since last year same period to ₹14.10Cr in the Q2 2024-2025. On a quarterly growth basis, SMS Pharmaceuticals Ltd has generated -14.44% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, SMS Pharmaceuticals Ltd has declared dividend of ₹0.40 - translating a dividend yield of 0.17%.
Read More about DividendsBearish
Neutral
Bullish
SMS Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
SMS Pharmaceuticals Ltd (SMSPHARMA) share price today is ₹231.55
SMS Pharmaceuticals Ltd is listed on NSE
SMS Pharmaceuticals Ltd is listed on BSE
PE Ratio of SMS Pharmaceuticals Ltd is 34.6
PE ratio = SMS Pharmaceuticals Ltd Market price per share / SMS Pharmaceuticals Ltd Earnings per share
Today’s traded volume of SMS Pharmaceuticals Ltd(SMSPHARMA) is 1.59L.
Today’s market capitalisation of SMS Pharmaceuticals Ltd(SMSPHARMA) is ₹2013.45Cr.
SMS Pharmaceuticals Ltd(SMSPHARMA | Price |
---|---|
52 Week High | ₹398 |
52 Week Low | ₹113.3 |
SMS Pharmaceuticals Ltd(SMSPHARMA) share price is ₹231.55. It is down -41.82% from its 52 Week High price of ₹398
SMS Pharmaceuticals Ltd(SMSPHARMA) share price is ₹231.55. It is up 104.37% from its 52 Week Low price of ₹113.3
SMS Pharmaceuticals Ltd(SMSPHARMA | Returns |
---|---|
1 Day Returns | -11.35% |
1 Month Returns | 1.5% |
3 Month Returns | -35.54% |
1 Year Returns | 104.89% |